24 IU intranasal oxytocin per therapy session: a tiny trial worth reading closely
From the regimen record: 24 IU, Intranasal, Before each psychotherapy session. n=23. Paper:…
Members only. Join to read the rest
For Research & Educational Discussion Only. Not Medical Advice
Nonapeptide hormone (posterior pituitary)
Also known as Pitocin, Syntocinon
An approved obstetric drug with a very large literature, and a second life as a social and behavioural intervention where the evidence is far weaker than the popular account of it.
CYIQNCPLGIn shortA hormone made in the brain and released by the pituitary. Its approved use is in childbirth: starting or strengthening labour and controlling bleeding afterwards. That use is old, well understood and uncontroversial. Almost everything else attached to its name is a different subject, and the popular framing of it as the bonding hormone rests on research with serious replication problems.
Oxytocin is a nine-amino-acid hormone produced in the hypothalamus and released from the posterior pituitary. Its approved use is obstetric: inducing or augmenting labour, and controlling postpartum bleeding. That use is old, well characterised and not controversial.
Almost everything else attached to its name is a different subject. The popular framing of oxytocin as a "bonding hormone" comes from a research literature that has had serious replication problems, and the gap between what that literature actually supports and what gets said about it is one of the wider ones in this compendium.
In shortIt makes the muscle of the womb contract and triggers milk release. Effects in the brain are proposed through receptors handling emotion and reward, and that is where the caution belongs. Behavioural studies usually use a nasal spray, and how much reaches the brain that way is unresolved. A result built on an unverified delivery assumption is fragile however clean the statistics look.
Acts at the oxytocin receptor, a G-protein-coupled receptor, causing uterine smooth muscle contraction and milk ejection. Central effects are proposed via receptors in the amygdala, hypothalamus and striatum.
The central story is where the caution belongs. Intranasal administration is the usual route in behavioural studies, and how much intranasal oxytocin reaches the brain, and in what concentration, is genuinely unresolved. A behavioural result built on an unverified delivery assumption is fragile no matter how clean the statistics look.
In shortFor childbirth: established, with decades of use and a large trial base. For social and psychiatric uses: much weaker than commonly presented. Early small studies reported striking effects on trust and empathy, and larger attempts to repeat them have often failed. Autism is the clearest example: promising early work, then a large trial that found no benefit.
For obstetric indications: established, with decades of use and a large trial base.
For social, behavioural and psychiatric indications: much weaker than commonly presented. Early small studies reported striking effects on trust, empathy and social cognition. Larger and pre-registered replications have often failed to reproduce them, and the field has been the subject of specific methodological criticism about small samples and flexible analysis.
Autism is the clearest example: promising early work, followed by a large well-conducted trial that did not find benefit on its primary endpoint.
In shortIn childbirth use it is well characterised and managed by clinicians, with known risks including over-contraction of the womb and, at high doses with large fluid volumes, dangerously low blood sodium. Nasal use in research reported mild effects, but the doses studied were short and repeated use is not characterised. The low-sodium risk is under-appreciated outside clinics.
In obstetric use, well characterised and managed by clinicians, with known risks including uterine hyperstimulation and, at high doses with large fluid volumes, hyponatraemia from its antidiuretic activity.
Intranasal use in research has generally reported mild effects, but the doses and durations studied are short, and long-term repeated use is not characterised. Hyponatraemia risk is the one that is under-appreciated outside clinical settings.
In shortApproved as a prescription medicine for obstetric use in most countries. Nasal versions for behavioural uses are not approved. Compounded or research-use-only oxytocin sold outside a pharmacy is a different product from the approved injection, and the approval does not travel with the name.
Approved as a prescription medicine for obstetric use in most jurisdictions. Intranasal formulations for behavioural indications are not approved and are investigational.
Compounded and research-use-only oxytocin sold outside a pharmacy is a different product from the approved injectable, and the approval does not travel with the name.
3 studies indexed. Findings and limitations get equal weight, on purpose.
Members area
Everything above is free to read. What an account opens is the evidence underneath it: 3 studies with their limitations, and the regimen each trial actually reported.
Free to create. A membership is separate, and you can decide about that later.
Reading is free, an account is not the same as paying. 43 compound guides, every study with its limitations written underneath, and the regimens those trials actually used. A free account opens all of it. A membership is a separate decision, and it opens the forum. What membership costs.
The wider literature
17 indexed papers and 33 registered trials mentioning Oxytocin, straight from PubMed and ClinicalTrials.gov. 28 of 33 administer it; the rest measure it. These have not been read by us. Unlike the studies above, they carry no findings and no limitations written by anyone here, because writing either would mean claiming a reading nobody has done. They are a starting point for yours.
State University of New York - Upstate Medical University2024NCT06045650
observationalunknownn=92
University of Fribourg2023NCT06084325
observationalcompletedn=110
Ohio State University2022NCT05289869
interventionalphase4completedn=20
Bezmialem Vakif University2021NCT05083910
interventionalnacompletedn=156
Ain Shams Maternity Hospital2021NCT04996498
interventionalnacompletedn=60
University of Florida2021NCT04218409
interventionalearly_phase1recruitingn=45
Yale University2021NCT05079841
interventionalphase4active not recruitingn=933
Medical University of South Carolina2021NCT04523922
interventionalphase2completedn=175
University of Electronic Science and Technology of China2021NCT05073939
interventionalnaunknownn=80
Bezmialem Vakif University2019NCT03967171
interventionalnacompletedn=101
Saglik Bilimleri Universitesi2019NCT04441125
observationalcompletedn=88
Cukurova University2019NCT04427410
observationalcompletedn=70
Zeynep Kamil Maternity and Pediatric Research and Training Hospital2018NCT03742531
interventionalphase2completedn=300
Massachusetts General Hospital2018NCT03337035
interventionalphase1completedn=35
University of Electronic Science and Technology of China2017NCT03074409
interventionalnacompletedn=83
Prof. Ilanit gordon2016NCT05096676
interventionalnacompletedn=58
Centre Hospitalier Universitaire de Besancon2015NCT02847143
interventionalphase2completedn=100
William Whang2013NCT01780337
interventionalearly_phase1completedn=12
Emory University2013NCT01568528
interventionalphase2completedn=39
University Hospital, Toulouse2013NCT02205034
interventionalphase1phase2completedn=18
VA Greater Los Angeles Healthcare System2012NCT01517360
interventionalphase1completedn=27
Tiffany Love2012NCT01722071
interventionalphase2completedn=20
Kevin Gray, MD2012NCT01576874
interventionalnacompletedn=144
Medical University of South Carolina2011NCT01963091
interventionalphase2completedn=33
Johns Hopkins Bloomberg School of Public Health2011NCT01108289
interventionalnacompletedn=1586
Puerta de Hierro University Hospital2011NCT01891201
observationalcompletedn=98
University of Maryland, Baltimore2010NCT01123317
interventionalnawithdrawnn=0
University of Zurich2010NCT01066299
interventionalnaunknownn=50
Poitiers University Hospital2010NCT01711060
interventionalnacompletedn=204
Erzincan Military Hospital2009NCT01099280
interventionalphase3completedn=225
National Institute on Drug Abuse (NIDA)2008NCT00975416
interventionalphase4terminatedn=63
Northwestern University2007NCT00787176
interventionalnaterminatedn=251
University of California, Irvine2004NCT00315913
interventionalphase2withdrawnn=0
Atila C, et al.BMJ open2026PMID 42082227
journal articleclinical trial protocol
Shea AE, et al.American journal of obstetrics and gynecology2025PMID 39892837
journal articlemulticenter studyrandomized controlled trial
Duong TV, et al.bioRxiv : the preprint server for biology2024PMID 39605626
journal articlepreprint
Dubey P, et al.bioRxiv : the preprint server for biology2024PMID 38559157
preprintjournal article
Ellenbogen MA, et al.Psychological medicine2024PMID 38445382
clinical trial, phase iijournal articlerandomized controlled trialresearch support, non-u.s. gov't
Hermesch AC, et al.American journal of obstetrics and gynecology2024PMID 37460365
reviewjournal article
Wilkinson CBest practice & research. Clinical obstetrics & gynaecology2021PMID 34556409
journal articlereview
Wesley BD, et al.American journal of obstetrics and gynecology2021PMID 34215352
journal articlereview
Thul TA, et al.Psychoneuroendocrinology2020PMID 32683141
journal articleresearch support, n.i.h., extramuralsystematic review
Calhoun BCIssues in law & medicine2016PMID 29108178
journal articlereview
2006PMID 30000550
review
Dodd J, et al.The Australian & New Zealand journal of obstetrics & gynaecology2004PMID 15387857
journal articlemeta-analysissystematic review
Long PA, et al.The Australian & New Zealand journal of obstetrics & gynaecology1981PMID 6942818
journal article
Pedlow PRThe Journal of obstetrics and gynaecology of the British Commonwealth1970PMID 5493616
journal article
HIBBARD LT, et al.California medicine1960PMID 14401672
journal article
DILLON TF, et al.Obstetrics and gynecology1958PMID 13590683
journal article
ARNOT PHCalifornia medicine1952PMID 14886755
journal article
Oxytocin has its own forum, split by the same six categories as the rest of the site.
From the regimen record: 24 IU, Intranasal, Before each psychotherapy session. n=23. Paper:…
Members only. Join to read the rest
Oxytocin is a Nonapeptide hormone (posterior pituitary) with an approved regulatory posture,…
Members only. Join to read the rest
Membership
The guide above is open to everyone, and the literature underneath it opens with a free account. That is the educational half of this site. Reading and joining the discussion around Oxytocin, and every other entry, is what membership pays for.
For Research & Educational Discussion Only. Not Medical Advice
This guide is educational reference material compiled from published literature. It is not medical advice, not a recommendation, and not a substitute for a clinician who knows your history. Nothing here should be used to make a decision about your own health without one.
Talk to a licensed healthcare professional.